The groundbreaking study shows early risk stratification of smoldering multiple myeloma, a precursor state to multiple myeloma, a deadly form of blood cancer. Multiple myeloma remains an incurable ...

Luis Malpica, MD, Department of Lymphoma and Myeloma, The University of Texas ... diagnosis and differential diagnosis, risk stratification, other prognostic factors, management, novel approaches ...

The authors conclude that CD19, CD28 and CD117 can be used to identify patients with multiple myeloma at high risk of disease progression.

This review of population-based registries and randomized controlled trials shows a pattern of increased risk for second primary malignancies in patients with multiple myeloma. It is unclear ...

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple myeloma, a type of blood cancer.

Saad Z. Usmani, MD, MBA, FACP, discusses how the AQUILA study data presented at ASH 2024, highlighting the benefits of early intervention in high-risk smoldering multiple myeloma, could impact ...